357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics
2026-06-15 · 80 min · episode 357 · 7 entities
Asserted relationships
-
0.55
evidence rules-v4
Feed author/publisher: Sean Carroll
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Physics
Entities found in this episode
concepts 5
-
0.50
evidence rules-v4
Feed category: Science
-
0.50
evidence rules-v4
Feed category: Physics
-
0.42
evidence rules-v4
357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Physics
persons 2
-
0.70
evidence rules-v4
Feed author/publisher: Sean Carroll
-
0.55
evidence rules-v4
Feed author/publisher: Sean Carroll
Episode description as stored
Messenger RNA (mRNA) plays a literally central role in the functioning of life as we know it, shuttling information back and forth between the DNA where it is stored to the ribosome where it is used to produce proteins. RNA may even have been the first molecule to kick-start the origin of life. Today, scientists are learning how to manipulate mRNA to cure and prevent diseases, whether through vaccination or literally editing one's DNA. Jeff Coller explains how it all works and how mRNA is revolutionizing medicine as we know it.
Blog post with transcript: https://www.preposterousuniverse.com/podcast/2026/06/15/357-jeff-coller-on-mrna-vaccines-and-bespoke-therapeutics/
Support Mindscape on Patreon .
Jeff Coller received his Ph.D. in cell and molecular biology from the University of Wisconsin-Madison. He is currently Bloomberg Distinguished Professor of Biomedical Engineering and Director of the RNA Innovation Center at Johns Hopkins University. He is co-founder of Tevard Biosciences and the Alliance for mRNA Medicines, and leads the REPAIRx consortium. He is a fellow of the American Association for the Advancement of Science.
Web site
Johns Hopkins web page
Google Scholar publications
"This May Be the Most Important Medical Story of the Decade," New York Times, April 9, 2026